The annual International Conferences on Radionuclide Therapy (14thICRT)

The 14th International Conference on Radiopharmaceutical Therapy was held in Nanjing. This conference On August 21-25, 2019. The conference have several subject,  including the integration of diagnosis and treatment of cardiovascular and cerebrovascular diseases, prostate cancer, neuroendocrine tumors and other diseases, as well as quality control and clinical care in nuclear medicine.
ICRT 2019 is the annual meeting of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). WARMTH is the only worldwide organization founded to promote the use of radionuclide molecular therapy, and of the relatively novel paradigm of ‘Theragnostics.’
It is a voluntary non-profit organization of individuals specifically associated for the purposes, and for using the means, to achieve research and educational objectives for the benefit of public health and humanity.
Jiangsu Huayi Technology Co., Ltd., parent company of Huayi Isotopes Co. participated in the conference with complete solutions of ⁶⁸Ga, ¹⁷⁷Lu labeled peptide, which attracted many customers to inquire and communicate.